EDETOX logo

IN VIVO STUDIES FURTHER DETAILS


BACK TO THE MAIN MENU

back to previous page forward to next page

University of Newcastle homepage

In Vivo Study No: 162

METHODS

ChemicalMembraneConcentration mg/mlConcentration mg/mlloading (mg/cm2)SpeciesSiteArea (cm2)Occluded?Exposure Time (h)Analytical Method
TestosteroneNot Given 0.004AcetoneHumanForearm13224Radiolabelled (14C)

RESULTS

Length of Study (h)% Recovery+/-Dose remaining on surface (mg)% remaining on SurfaceDose remaining in stratum corneum (mg)% remaining in stratum corneumDose remaining in the viable skin% remaining in the viable skinAmount Absorbed (mg)% Absorbed+/-% Absorbed
120        0.0068813.243.0413.24
Maximal Flux (mcrg/cm2/h)Average Flux (mcrg/cm2/h)+/-Time Plasma/Blood Levels Peaked (h)Peak Blood Concentration (mg/l)nkp (cm/h)Lag Time (h)
     17  

NOTES

The % absorption was calculated by measuring the amount excreted in the urine and comparing this with the amount excreted after a parenteral dose. The skin area was enclosed in a ring of petrolatum. The acetone was evaporated in less than 15 seconds from the application.

REFERENCE

Percutaneous Penetration Of Steroids In Man (1969) J. Investig. Dermatol., 52 :89-94